On the public citation graph

Combining immunotherapy and targeted therapies in cancer treatment

0 signed · 1686 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cncr.24468openalex-snapshot
Synthetic tumor‐specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease
inferredcites →https://doi.org/10.1002/eji.200324181openalex-snapshot
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
inferredcites →https://doi.org/10.1002/hep.24652openalex-snapshot
Regression of Established Hepatocellular Carcinoma Is Induced by Chemoimmunotherapy in An Orthotopic Murine Model
inferredcites →https://doi.org/10.1002/ijc.25863openalex-snapshot
Sunitinib facilitates the activation and recruitment of therapeutic anti‐tumor immunity in concert with specific vaccination
inferredcites →https://doi.org/10.1002/ijc.26181openalex-snapshot
Cetuximab ± chemotherapy enhances dendritic cell‐mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen‐specific cytotoxic T‐cell response in vitro
inferredcites →https://doi.org/10.1002/ijc.26219openalex-snapshot
Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapy
inferredcites →https://doi.org/10.1007/82_2010_51openalex-snapshot
STAT3: A Target to Enhance Antitumor Immune Response
inferredcites →https://doi.org/10.1007/s00109-008-0370-yopenalex-snapshot
Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination
inferredcites →https://doi.org/10.1007/s00262-008-0583-5openalex-snapshot
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
inferredcites →https://doi.org/10.1007/s12026-011-8231-0openalex-snapshot
Natural killer (NK):dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity
inferredcites →https://doi.org/10.1016/j.ccr.2010.06.014openalex-snapshot
The Therapeutic Effect of Anti-HER2/neu Antibody Depends on Both Innate and Adaptive Immunity
inferredcites →https://doi.org/10.1016/j.ccr.2010.10.002openalex-snapshot
CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation
inferredcites →https://doi.org/10.1016/j.ccr.2011.04.016openalex-snapshot
Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
inferredcites →https://doi.org/10.1016/j.ceb.2011.08.006openalex-snapshot
TOR in the immune system
inferredcites →https://doi.org/10.1016/j.cell.2010.01.025openalex-snapshot
Immunity, Inflammation, and Cancer
inferredcites →https://doi.org/10.1016/j.cell.2011.03.026openalex-snapshot
The Evolving War on Cancer
inferredcites →https://doi.org/10.1016/j.cell.2011.12.031openalex-snapshot
Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model
inferredcites →https://doi.org/10.1016/j.immuni.2010.11.024openalex-snapshot
An Oscillatory Switch in mTOR Kinase Activity Sets Regulatory T Cell Responsiveness
inferredcites →https://doi.org/10.1016/j.leukres.2008.09.006openalex-snapshot
The dysfunction and abnormal signaling pathway of dendritic cells loaded by tumor antigen can be overcome by neutralizing VEGF in multiple myeloma
inferredcites →https://doi.org/10.1016/j.molcel.2004.12.030openalex-snapshot
Differential Targeting of Prosurvival Bcl-2 Proteins by Their BH3-Only Ligands Allows Complementary Apoptotic Function
inferredcites →https://doi.org/10.1016/j.molimm.2010.05.003openalex-snapshot
The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells
inferredcites →https://doi.org/10.1016/s0065-230x(04)91001-9openalex-snapshot
Imatinib as a Paradigm of Targeted Therapies
inferredcites →https://doi.org/10.1016/s0065-2776(06)90008-xopenalex-snapshot
Checkpoint Blockade in Cancer Immunotherapy
inferredcites →https://doi.org/10.1016/s0065-2776(08)60911-6openalex-snapshot
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
inferredcites →https://doi.org/10.1016/s0140-6736(07)61904-7openalex-snapshot
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
inferredcites →https://doi.org/10.1016/s1470-2045(11)70259-5openalex-snapshot
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial
inferredcites →https://doi.org/10.1038/bjc.2011.15openalex-snapshot
Temsirolimus, an mTOR inhibitor, enhances anti-tumour effects of heat shock protein cancer vaccines
inferredcites →https://doi.org/10.1038/bjc.2011.261openalex-snapshot
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival
inferredcites →https://doi.org/10.1038/cr.2009.80openalex-snapshot
Enhancement of TRAIL cytotoxicity by AG-490 in human ALL cells is characterized by downregulation of cIAP-1 and cIAP-2 through inhibition of Jak2/Stat3
inferredcites →https://doi.org/10.1038/leu.2008.354openalex-snapshot
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
inferredcites →https://doi.org/10.1038/mt.2008.255openalex-snapshot
Activation of Akt as a Mechanism for Tumor Immune Evasion
inferredcites →https://doi.org/10.1038/nature04483openalex-snapshot
Angiogenesis as a therapeutic target
inferredcites →https://doi.org/10.1038/nature08155openalex-snapshot
mTOR regulates memory CD8 T-cell differentiation
inferredcites →https://doi.org/10.1038/nature10673openalex-snapshot
Cancer immunotherapy comes of age
inferredcites →https://doi.org/10.1038/nm.2438openalex-snapshot
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
inferredcites →https://doi.org/10.1038/nm.2446openalex-snapshot
A human memory T cell subset with stem cell–like properties
inferredcites →https://doi.org/10.1038/nm0697-682openalex-snapshot
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
inferredcites →https://doi.org/10.1038/nm1769openalex-snapshot
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination
inferredcites →https://doi.org/10.1038/nrc1736openalex-snapshot
Promoting apoptosis as a strategy for cancer drug discovery
inferredcites →https://doi.org/10.1038/nrc3239openalex-snapshot
The blockade of immune checkpoints in cancer immunotherapy
inferredcites →https://doi.org/10.1038/nrclinonc.2010.223openalex-snapshot
Immune parameters affecting the efficacy of chemotherapeutic regimens
inferredcites →https://doi.org/10.1038/nri3129openalex-snapshot
Experimental mouse tumour models: what can be learnt about human cancer immunology?
inferredcites →https://doi.org/10.1038/nrm2918openalex-snapshot
HSP90 at the hub of protein homeostasis: emerging mechanistic insights
inferredcites →https://doi.org/10.1038/sj.bjc.6604965openalex-snapshot
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
inferredcites →https://doi.org/10.1038/sj.mt.6300014openalex-snapshot
Inhibitor of Heat-shock Protein 90 Enhances the Antitumor Effect of DNA Vaccine Targeting Clients of Heat-shock Protein
inferredcites →https://doi.org/10.1039/b911313bopenalex-snapshot
Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination?
inferredcites →https://doi.org/10.1056/nejmoa022457openalex-snapshot
Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
inferredcites →https://doi.org/10.1056/nejmoa051424openalex-snapshot
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
inferredcites →https://doi.org/10.1056/nejmoa1001294openalex-snapshot
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
inferredcites →https://doi.org/10.1056/nejmoa1003466openalex-snapshot
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1004095openalex-snapshot
Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
inferredcites →https://doi.org/10.1056/nejmoa1103782openalex-snapshot
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
inferredcites →https://doi.org/10.1056/nejmoa1104621openalex-snapshot
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
inferredcites →https://doi.org/10.1073/pnas.0712237105openalex-snapshot
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
inferredcites →https://doi.org/10.1073/pnas.0915174107openalex-snapshot
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
inferredcites →https://doi.org/10.1073/pnas.1016569108openalex-snapshot
Anti–ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti–PD-1 or anti-CD137 mAb therapy
inferredcites →https://doi.org/10.1084/jem.20051848openalex-snapshot
The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells
inferredcites →https://doi.org/10.1084/jem.20101123openalex-snapshot
IAP inhibitors enhance co-stimulation to promote tumor immunity
inferredcites →https://doi.org/10.1097/mpa.0b013e31822398c6openalex-snapshot
Clinical and Immunologic Evaluation of Dendritic Cell–Based Immunotherapy in Combination With Gemcitabine and/or S-1 in Patients With Advanced Pancreatic Carcinoma
inferredcites →https://doi.org/10.1111/j.1349-7006.2007.00545.xopenalex-snapshot
Inhibition of GSK‐3β activity attenuates proliferation of human colon cancer cells in rodents
inferredcites →https://doi.org/10.1111/j.1365-2141.2011.08882.xopenalex-snapshot
Biological effects and clinical significance of lenalidomide‐induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response
inferredcites →https://doi.org/10.1126/science.1099688openalex-snapshot
Immunotherapy: Bewitched, Bothered, and Bewildered No More
inferredcites →https://doi.org/10.1146/annurev.immunol.021908.132544openalex-snapshot
Immune Therapy for Cancer
inferredcites →https://doi.org/10.1146/annurev.immunol.23.021704.115611openalex-snapshot
THE B7 FAMILY REVISITED
inferredcites →https://doi.org/10.1146/annurev.immunol.25.022106.141609openalex-snapshot
Immunosuppressive Strategies that are Mediated by Tumor Cells
inferredcites →https://doi.org/10.1146/annurev.immunol.26.021607.090331openalex-snapshot
PD-1 and Its Ligands in Tolerance and Immunity
inferredcites →https://doi.org/10.1146/annurev.med.57.042905.122625openalex-snapshot
Bortezomib: Proteasome Inhibition as an Effective Anticancer Therapy
inferredcites →https://doi.org/10.1158/0008-5472.can-03-2646openalex-snapshot
Surgical Removal of Primary Tumor Reverses Tumor-Induced Immunosuppression Despite the Presence of Metastatic Disease
inferredcites →https://doi.org/10.1158/0008-5472.can-05-0529openalex-snapshot
Regulation of Dendritic Cell Differentiation and Antitumor Immune Response in Cancer by Pharmacologic-Selective Inhibition of the Janus-Activated Kinase 2/Signal Transducers and Activators of Transcription 3 Pathway
inferredcites →https://doi.org/10.1158/0008-5472.can-05-0599openalex-snapshot
Cancer Cells Become Susceptible to Natural Killer Cell Killing after Exposure to Histone Deacetylase Inhibitors Due to Glycogen Synthase Kinase-3–Dependent Expression of MHC Class I–Related Chain A and B
inferredcites →https://doi.org/10.1158/0008-5472.can-05-2128openalex-snapshot
Combination Therapy with Anti–CTL Antigen-4 and Anti-4-1BB Antibodies Enhances Cancer Immunity and Reduces Autoimmunity
inferredcites →https://doi.org/10.1158/0008-5472.can-05-4603openalex-snapshot
The DNA Damage Response Arouses the Immune System
inferredcites →https://doi.org/10.1158/0008-5472.can-07-6226openalex-snapshot
Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies
inferredcites →https://doi.org/10.1158/0008-5472.can-07-6286openalex-snapshot
Targeting AKT Signaling Sensitizes Cancer to Cellular Immunotherapy
inferredcites →https://doi.org/10.1158/0008-5472.can-08-3807openalex-snapshot
Natural Killer Cell IFN-γ Levels Predict Long-term Survival with Imatinib Mesylate Therapy in Gastrointestinal Stromal Tumor–Bearing Patients
inferredcites →https://doi.org/10.1158/0008-5472.can-08-4511openalex-snapshot
Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells
inferredcites →https://doi.org/10.1158/0008-5472.can-08-4709openalex-snapshot
The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
inferredcites →https://doi.org/10.1158/0008-5472.can-09-3175openalex-snapshot
The Proteasome Inhibitor Bortezomib Sensitizes Melanoma Cells toward Adoptive CTL Attack
inferredcites →https://doi.org/10.1158/0008-5472.can-09-3690openalex-snapshot
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity
inferredcites →https://doi.org/10.1158/0008-5472.can-10-0118openalex-snapshot
Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function
inferredcites →https://doi.org/10.1158/0008-5472.can-10-0153openalex-snapshot
Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer
inferredcites →https://doi.org/10.1158/0008-5472.can-10-1293openalex-snapshot
Targeting STAT3 in Adoptively Transferred T Cells Promotes Their In Vivo Expansion and Antitumor Effects
inferredcites →https://doi.org/10.1158/0008-5472.can-10-3968openalex-snapshot
mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer Treatment
inferredcites →https://doi.org/10.1158/0008-5472.can-11-0268openalex-snapshot
Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
inferredcites →https://doi.org/10.1158/1078-0432.ccr-05-0883openalex-snapshot
Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-1332openalex-snapshot
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-1825openalex-snapshot
Anti–Programmed Death-1 Synergizes with Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Cell Immunotherapy Providing Therapeutic Benefit to Mice with Established Tumors
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-0213openalex-snapshot
Heat Shock Protein 90 Inhibitor BIIB021 (CNF2024) Depletes NF-κB and Sensitizes Hodgkin's Lymphoma Cells for Natural Killer Cell–Mediated Cytotoxicity
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-0973openalex-snapshot
Deregulated GSK3 Sustains Gastrointestinal Cancer Cells Survival by Modulating Human Telomerase Reverse Transcriptase and Telomerase
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-1624openalex-snapshot
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-3243openalex-snapshot
Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
inferredcites →https://doi.org/10.1158/1078-0432.ccr-11-0239openalex-snapshot
Activation of Tumor-Promoting Type 2 Macrophages by EGFR-Targeting Antibody Cetuximab
inferredcites →https://doi.org/10.1158/1535-7163.mct-09-0820openalex-snapshot
A phase I trial of paclitaxel and trastuzumab in combination with interleukin-12 in patients with HER2/neu-expressing malignancies
inferredcites →https://doi.org/10.1159/000320609openalex-snapshot
Immunological Effects of Bevacizumab-Based Treatment in Metastatic Colorectal Cancer
inferredcites →https://doi.org/10.1159/000453569openalex-snapshot
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
inferredcites →https://doi.org/10.1172/jci24772openalex-snapshot
Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions
inferredcites →https://doi.org/10.1172/jci34333openalex-snapshot
Antibody association with HER-2/neu–targeted vaccine enhances CD8+ T cell responses in mice through Fc-mediated activation of DCs
inferredcites →https://doi.org/10.1172/jci35180openalex-snapshot
The anticancer immune response: indispensable for therapeutic success?
inferredcites →https://doi.org/10.1182/blood-2007-02-075945openalex-snapshot
Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses
inferredcites →https://doi.org/10.1182/blood-2007-03-078535openalex-snapshot
Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell–mediated lysis of myeloma
inferredcites →https://doi.org/10.1182/blood-2010-02-271874openalex-snapshot
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody
inferredcites →https://doi.org/10.1182/blood-2010-04-279893openalex-snapshot
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma
inferredcites →https://doi.org/10.1182/blood-2010-05-282780openalex-snapshot
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
inferredcites →https://doi.org/10.1182/blood-2010-11-315705openalex-snapshot
The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia
inferredcites →https://doi.org/10.1182/blood-2011-06-360255openalex-snapshot
IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect
inferredcites →https://doi.org/10.1186/1471-2407-10-340openalex-snapshot
Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients
inferredcites →https://doi.org/10.1186/1476-4598-9-139openalex-snapshot
Complement activation mediates cetuximab inhibition of non-small cell lung cancer tumor growth in vivo
inferredcites →https://doi.org/10.1189/jlb.0711339openalex-snapshot
Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression
inferredcites →https://doi.org/10.1200/jco.2003.10.589openalex-snapshot
Imatinib As a Paradigm of Targeted Therapies
inferredcites →https://doi.org/10.1200/jco.2008.20.6789openalex-snapshot
Concurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast Cancer
inferredcites →https://doi.org/10.1200/jco.2009.23.7370openalex-snapshot
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
inferredcites →https://doi.org/10.1200/jco.2010.29.5865openalex-snapshot
Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) –Positive Breast Cancer After Prior HER2-Directed Therapy
inferredcites →https://doi.org/10.1200/jco.2010.32.7270openalex-snapshot
Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
inferredcites →https://doi.org/10.1371/journal.pone.0018925openalex-snapshot
Imatinib Treatment Induces CD5+ B Lymphocytes and IgM Natural Antibodies with Anti-Leukemic Reactivity in Patients with Chronic Myelogenous Leukemia
inferredcites →https://doi.org/10.3324/haematol.13783openalex-snapshot
Proteasome inhibition induces apoptosis in primary human natural killer cells and suppresses NKp46-mediated cytotoxicity
inferredcites →https://doi.org/10.4049/jimmunol.0802793openalex-snapshot
Central Role of Tumor-Associated CD8+ T Effector/Memory Cells in Restoring Systemic Antitumor Immunity
inferredcites →https://doi.org/10.4049/jimmunol.0901797openalex-snapshot
Heat Shock Protein-90 Inhibitors Increase MHC Class I-Related Chain A and B Ligand Expression on Multiple Myeloma Cells and Their Ability to Trigger NK Cell Degranulation
inferredcites →https://doi.org/10.4049/jimmunol.0903805openalex-snapshot
Regulatory T Cells Require Mammalian Target of Rapamycin Signaling To Maintain Both Homeostasis and Alloantigen-Driven Proliferation in Lymphocyte-Replete Mice
inferredcites →https://doi.org/10.4049/jimmunol.1000222openalex-snapshot
EC144, a Synthetic Inhibitor of Heat Shock Protein 90, Blocks Innate and Adaptive Immune Responses in Models of Inflammation and Autoimmunity
inferredcites →https://doi.org/10.4049/jimmunol.1000328openalex-snapshot
IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN-γ Production
inferredcites →https://doi.org/10.4049/jimmunol.164.7.3596openalex-snapshot
Indoleamine 2,3-Dioxygenase Production by Human Dendritic Cells Results in the Inhibition of T Cell Proliferation
inferredcites →https://doi.org/10.4049/jimmunol.169.4.1792openalex-snapshot
4-1BB-Specific Monoclonal Antibody Promotes the Generation of Tumor-Specific Immune Responses by Direct Activation of CD8 T Cells in a CD40-Dependent Manner
inferredcites →https://doi.org/10.4049/jimmunol.171.4.2161openalex-snapshot
HER-2/neu-Specific Monoclonal Antibodies Collaborate with HER-2/neu-Targeted Granulocyte Macrophage Colony-Stimulating Factor Secreting Whole Cell Vaccination to Augment CD8+ T Cell Effector Function and Tumor-Free Survival in Her-2/ neu -Transgenic Mice
inferredcites →https://doi.org/10.4049/jimmunol.175.7.4338openalex-snapshot
Activation of Dendritic Cells via Inhibition of Jak2/STAT3 Signaling
inferredcites →https://doi.org/10.4049/jimmunol.178.12.7730openalex-snapshot
Phenotypic and Functional Effects of Heat Shock Protein 90 Inhibition on Dendritic Cell
inferredcites →https://doi.org/10.4049/jimmunol.180.1.163openalex-snapshot
Sensitization of Tumor Cells to NK Cell-Mediated Killing by Proteasome Inhibition
inferredcites →https://doi.org/10.4049/jimmunol.181.10.6797openalex-snapshot
IFN-β Production by TLR4-Stimulated Innate Immune Cells Is Negatively Regulated by GSK3-β
inferredcites →https://doi.org/10.4049/jimmunol.181.10.6955openalex-snapshot
Imatinib Mesylate Inhibits CD4+CD25+ Regulatory T Cell Activity and Enhances Active Immunotherapy against BCR-ABL− Tumors
inferredcites →https://doi.org/10.4161/cc.7.11.5959openalex-snapshot
(Un)expected roles of c-IAPs in apoptotic and NFκB signaling pathways

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4824779openalex-extracted
Photothermal Therapy Improves the Efficacy of Topical Immunotherapy Against Melanoma
inferred← citeshttps://doi.org/10.1001/jamaoncol.2015.1377openalex-snapshot
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma
inferred← citeshttps://doi.org/10.1002/14651858.cd014523openalex-snapshot
Immune checkpoint inhibitors for advanced pancreatic cancer
inferred← citeshttps://doi.org/10.1002/1873-3468.13521openalex-snapshot
HDAC2‐dependent miRNA signature in acute myeloid leukemia
inferred← citeshttps://doi.org/10.1002/9780470015902.a0002176.pub3openalex-snapshot
Monoclonal Antibodies: Therapeutic Uses
inferred← citeshttps://doi.org/10.1002/9780470015902.a0026247openalex-snapshot
Combination Therapy in Cancer
inferred← citeshttps://doi.org/10.1002/9781118468678.ch2openalex-snapshot
Combining Targeted Therapies
inferred← citeshttps://doi.org/10.1002/9781118468678.ch3openalex-snapshot
Principles of Targeted Immunotherapy
inferred← citeshttps://doi.org/10.1002/9781118468678.ch37openalex-snapshot
Future Perspectives
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm070openalex-snapshot
Cancer Nanotechnology
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm070.pub2openalex-snapshot
Cancer Nanotechnology
inferred← citeshttps://doi.org/10.1002/9783527674381.ch5openalex-snapshot
Personalized Medicine
inferred← citeshttps://doi.org/10.1002/9783527676965.ch8openalex-snapshot
Promises and Challenges with Immunomodulatory Biologics
inferred← citeshttps://doi.org/10.1002/9783527682423.ch2openalex-snapshot
Selection Strategies for Monoclonal Antibodies
inferred← citeshttps://doi.org/10.1002/9783527818341.ch5openalex-snapshot
Microfluidics for Immuno‐oncology
inferred← citeshttps://doi.org/10.1002/9783527838561.ch1openalex-snapshot
An Overview of Cancer
inferred← citeshttps://doi.org/10.1002/adbi.201600009openalex-snapshot
Combating Established Mouse Glioblastoma through Nicotinylated‐Liposomes‐Mediated Targeted Chemotherapy in Combination with Dendritic‐Cell‐Based Genetic Immunization
inferred← citeshttps://doi.org/10.1002/adbi.201800232openalex-snapshot
Progress in Tumor‐Associated Macrophages: From Bench to Bedside
inferred← citeshttps://doi.org/10.1002/adfm.201400456openalex-snapshot
Synergistic Enhancement of Lung Cancer Therapy Through Nanocarrier‐Mediated Sequential Delivery of Superantigen and Tyrosin Kinase Inhibitor
inferred← citeshttps://doi.org/10.1002/adfm.201802540openalex-snapshot
Toward Biomaterials for Enhancing Immune Checkpoint Blockade Therapy
inferred← citeshttps://doi.org/10.1002/adhm.201500080openalex-snapshot
An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects
inferred← citeshttps://doi.org/10.1002/adhm.202002104openalex-snapshot
Immune Checkpoint Inhibitor‐Based Strategies for Synergistic Cancer Therapy
inferred← citeshttps://doi.org/10.1002/adhm.202101944openalex-snapshot
Arming Immune Cell Therapeutics with Polymeric Prodrugs
inferred← citeshttps://doi.org/10.1002/adhm.202302016openalex-snapshot
One‐Pot Synthesis of Tumor‐Microenvironment Responsive Degradable Nanoflower‐Medicine for Multimodal Cancer Therapy with Reinvigorating Antitumor Immunity
inferred← citeshttps://doi.org/10.1002/adhm.202402066openalex-snapshot
Nanozymes in Biomedical Applications: Innovations Originated From Metal‐Organic Frameworks
inferred← citeshttps://doi.org/10.1002/adhm.202502779openalex-snapshot
Dual‐Mode Hybrid Discharge Plasma‐Activated Injectable Hydrosol for Enhanced Immunotherapeutic Cancer Therapy
inferred← citeshttps://doi.org/10.1002/adma.201704136openalex-snapshot
Synthesis of BSA‐Coated BiOI@Bi 2 S 3 Semiconductor Heterojunction Nanoparticles and Their Applications for Radio/Photodynamic/Photothermal Synergistic Therapy of Tumor
inferred← citeshttps://doi.org/10.1002/adma.201704408openalex-snapshot
Antigen‐Directed Fabrication of a Multifunctional Nanovaccine with Ultrahigh Antigen Loading Efficiency for Tumor Photothermal‐Immunotherapy
inferred← citeshttps://doi.org/10.1002/adma.201706320openalex-snapshot
Near‐Infrared‐Light‐Activatable Nanomaterial‐Mediated Phototheranostic Nanomedicines: An Emerging Paradigm for Cancer Treatment
inferred← citeshttps://doi.org/10.1002/adma.201808303openalex-snapshot
Tailoring Nanomaterials for Targeting Tumor‐Associated Macrophages
inferred← citeshttps://doi.org/10.1002/adma.202007630openalex-snapshot
Recent Advances in Engineered Materials for Immunotherapy‐Involved Combination Cancer Therapy
inferred← citeshttps://doi.org/10.1002/adma.202102188openalex-snapshot
Plasmon‐Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway
inferred← citeshttps://doi.org/10.1002/adma.202206370openalex-snapshot
Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy
inferred← citeshttps://doi.org/10.1002/adma.202313188openalex-snapshot
Engineered Bio‐Based Hydrogels for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/adma.202502758openalex-snapshot
Signal Transducer Nanoparticles Enable Siglec‐10/G Blockade Immunotherapy for Breast Cancer Treatment
inferred← citeshttps://doi.org/10.1002/adom.202000390openalex-snapshot
Deep Fluorescence Imaging by Laser‐Scanning Excitation and Artificial Neural Network Processing
inferred← citeshttps://doi.org/10.1002/adtp.202100058openalex-snapshot
Thiophene Derivative‐Loaded Nanoparticles Mediate Anticancer Activity Through the Inhibition of Kinases and Microtubule Assembly
inferred← citeshttps://doi.org/10.1002/adtp.202200020openalex-snapshot
Breaking Immunosuppressive Barriers by Engineered Nanoplatforms for Turning Cold Tumor to Hot
inferred← citeshttps://doi.org/10.1002/adtp.202200298openalex-snapshot
In Vitro Study on AI‐PRS Enabled Precision Cocktail Drugs Design for Treating Human Colorectal Carcinoma
inferred← citeshttps://doi.org/10.1002/advs.201802157openalex-snapshot
NIR‐Triggered Phototherapy and Immunotherapy via an Antigen‐Capturing Nanoplatform for Metastatic Cancer Treatment
inferred← citeshttps://doi.org/10.1002/advs.201802281openalex-snapshot
Cowpea Mosaic Virus Immunotherapy Combined with Cyclophosphamide Reduces Breast Cancer Tumor Burden and Inhibits Lung Metastasis
inferred← citeshttps://doi.org/10.1002/advs.202305382openalex-snapshot
Dual‐Responsive Supramolecular Polymeric Nanomedicine for Self‐Cascade Amplified Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/advs.202411898openalex-snapshot
Triplet Electron Exchange in Carbon Nanodots‐assisted Long‐persistent near‐infrared Chemiluminescence for Oncology Synergistic Imaging and Therapy
inferred← citeshttps://doi.org/10.1002/advs.202504603openalex-snapshot
Microwave‐Activated Bacterial Biorobot for Multimodal Cancer Therapy
inferred← citeshttps://doi.org/10.1002/advs.77223openalex-snapshot
Single‐Dose TACE‐Like Injection of Sustained‐Release Panobinostat/IL‐12 Polymeric Microparticles is Effective in Preclinical Liver Cancer Models
inferred← citeshttps://doi.org/10.1002/ange.201911429openalex-snapshot
A Nanoscale Metal–Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/ange.201914453openalex-snapshot
Diselenide–Pemetrexed Assemblies for Combined Cancer Immuno‐, Radio‐, and Chemotherapies
inferred← citeshttps://doi.org/10.1002/ange.202116669openalex-snapshot
Semiconducting Polymer Nano‐regulators with Cascading Activation for Photodynamic Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/ange.202202409openalex-snapshot
Decorating Bacteria with Triple Immune Nanoactivators Generates Tumor‐Resident Living Immunotherapeutics
inferred← citeshttps://doi.org/10.1002/ange.202305200openalex-snapshot
Activatable Semiconducting Polymer Pro‐nanomodulators for Deep‐Tissue Sono‐immunotherapy of Orthotopic Pancreatic Cancer
inferred← citeshttps://doi.org/10.1002/anie.201911429openalex-snapshot
A Nanoscale Metal–Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/anie.201914453openalex-snapshot
Diselenide–Pemetrexed Assemblies for Combined Cancer Immuno‐, Radio‐, and Chemotherapies
inferred← citeshttps://doi.org/10.1002/anie.202116669openalex-snapshot
Semiconducting Polymer Nano‐regulators with Cascading Activation for Photodynamic Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1002/anie.202202409openalex-snapshot
Decorating Bacteria with Triple Immune Nanoactivators Generates Tumor‐Resident Living Immunotherapeutics
inferred← citeshttps://doi.org/10.1002/anie.202305200openalex-snapshot
Activatable Semiconducting Polymer Pro‐nanomodulators for Deep‐Tissue Sono‐immunotherapy of Orthotopic Pancreatic Cancer
inferred← citeshttps://doi.org/10.1002/asia.201801088openalex-snapshot
Mannose‐Functionalized Nanoscaffolds for Targeted Delivery in Biomedical Applications
inferred← citeshttps://doi.org/10.1002/bab.2356openalex-snapshot
Targeted therapies in non‐small cell lung cancer and the potential role of AI interventions in cancer treatment
inferred← citeshttps://doi.org/10.1002/bimj.202100297openalex-snapshot
Bayesian two‐stage sequential enrichment design for biomarker‐guided phase II trials for anticancer therapies
inferred← citeshttps://doi.org/10.1002/biot.201400109openalex-snapshot
Personalized medicine approaches for colon cancer driven by genomics and systems biology: OncoTrack
inferred← citeshttps://doi.org/10.1002/cam4.1087openalex-snapshot
The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer
inferred← citeshttps://doi.org/10.1002/cam4.3346openalex-snapshot
Intestinal microbiota regulates anti‐tumor effect of disulfiram combined with Cu2+ in a mice model
inferred← citeshttps://doi.org/10.1002/cam4.5924openalex-snapshot
Safety and efficacy of GEMOX plus donafenib and tislelizumab as first‐line therapy for advanced epithelial malignant biliary tract cancer
inferred← citeshttps://doi.org/10.1002/cam4.6844openalex-snapshot
Pan‐cancer analysis of TIM ‐3 transcriptomic expression reveals high levels in pancreatic cancer and interpatient heterogeneity
inferred← citeshttps://doi.org/10.1002/cam4.7285openalex-snapshot
The role of ATP‐binding cassette subfamily G member 1 in tumor progression
inferred← citeshttps://doi.org/10.1002/cam4.754openalex-snapshot
Higher preoperative serum levels of PD ‐L1 and B7‐H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF ‐targeted therapy and unfavorable prognosis of renal cell carcinoma
inferred← citeshttps://doi.org/10.1002/cbic.201700246openalex-snapshot
Self‐Assembled Nano‐Immunostimulant for Synergistic Immune Activation
inferred← citeshttps://doi.org/10.1002/cbic.202200582openalex-snapshot
Self‐Assembling Peptide‐Based Functional Biomaterials
inferred← citeshttps://doi.org/10.1002/cncr.70581openalex-snapshot
The evolving role of immunotherapy in ovarian cancer
inferred← citeshttps://doi.org/10.1002/ctm2.254openalex-snapshot
Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2‐targeted therapies
inferred← citeshttps://doi.org/10.1002/ddr.70167openalex-snapshot
Targeting mTOR Kinase for Cancer Treatment: A Comprehensive Review With Clinical Insights
inferred← citeshttps://doi.org/10.1002/ddr.70184openalex-snapshot
Integration of Machine Learning, Bioinformatics, and Experimental Validation to Identify Novel Diagnostic and Prognostic Biomarkers Associated With Succinylation in Lung Adenocarcinoma
inferred← citeshttps://doi.org/10.1002/elsc.70015openalex-snapshot
Recombinant Expression of a Ready‐to‐Use EGF Variant Equipped With a Single Conjugation Site for Click‐Chemistry
inferred← citeshttps://doi.org/10.1002/exp.20210263openalex-snapshot
Biomimetic and bioinspired nano‐platforms for cancer vaccine development
inferred← citeshttps://doi.org/10.1002/iid3.144openalex-snapshot
Location of tumor affects local and distant immune cell type and number
inferred← citeshttps://doi.org/10.1002/ijc.28794openalex-snapshot
Transcriptomic analysis of a transgenic zebrafish hepatocellular carcinoma model reveals a prominent role of immune responses in tumour progression and regression
inferred← citeshttps://doi.org/10.1002/ijc.29190openalex-snapshot
T cell‐based targeted immunotherapies for patients with multiple myeloma
inferred← citeshttps://doi.org/10.1002/ijc.29606openalex-snapshot
Expression of the mi R ‐302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes
inferred← citeshttps://doi.org/10.1002/ijc.29713openalex-snapshot
Synergistic antitumor responses by combined GITR activation and sunitinib in metastatic renal cell carcinoma
inferred← citeshttps://doi.org/10.1002/ijc.32343openalex-snapshot
Beyond the tumour microenvironment
inferred← citeshttps://doi.org/10.1002/ijgo.70360openalex-snapshot
Research progress of adoptive tumor infiltrating lymphocyte therapy for cervical cancer
inferred← citeshttps://doi.org/10.1002/inmd.20240083openalex-snapshot
A facile automated multiple‐well platform of immunized tumor organoid cultures in ECM‐mimicked hydrogels for chem‐immunotherapy evaluation
inferred← citeshttps://doi.org/10.1002/jbio.201800149openalex-snapshot
Photothermal therapy enhanced the effectiveness of imiquimod against refractory cutaneous warts through boosting immune responses
inferred← citeshttps://doi.org/10.1002/jbt.23135openalex-snapshot
Preparation, DFT calculations, docking studies, antioxidant, and anticancer properties of new pyrazole and pyridine derivatives
inferred← citeshttps://doi.org/10.1002/jbt.23233openalex-snapshot
Ropivacaine inhibits proliferation and invasion and promotes apoptosis and autophagy in bladder cancer cells via inhibiting PI3K/AKT pathway
inferred← citeshttps://doi.org/10.1002/jbt.71025openalex-snapshot
Synthesis, Anticancer Evaluation, mRNA Expression Analysis, and Molecular Docking of Fluorinated Picolinamide–Benzothiazole Derivatives Against Breast Cancer‐Related Genes CDK2, ERK2, and BCL2
inferred← citeshttps://doi.org/10.1002/jcb.28782openalex-snapshot
Cancer drug resistance: A fleet to conquer
inferred← citeshttps://doi.org/10.1002/jcph.591openalex-snapshot
Immune Checkpoint inhibitors: An introduction to the next‐generation cancer immunotherapy
inferred← citeshttps://doi.org/10.1002/mc.23419openalex-snapshot
Functional characterization and clinical significance of super‐enhancers in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1002/mrc.4508openalex-snapshot
Preliminary study of mechanism of action of SN38 derivatives. Physicochemical data, evidence of interaction and alkylation of DNA octamer d(GCGATCGC)2
inferred← citeshttps://doi.org/10.1002/path.4285openalex-snapshot
Mouse tumour models to guide drug development and identify resistance mechanisms
inferred← citeshttps://doi.org/10.1002/pon.5011openalex-snapshot
Effectiveness of interventions to improve cancer treatment and follow‐up care in socially disadvantaged groups
inferred← citeshttps://doi.org/10.1002/ppap.201400068openalex-snapshot
Reactive Species from Cold Atmospheric Plasma: Implications for Cancer Therapy
inferred← citeshttps://doi.org/10.1002/ppsc.201400140openalex-snapshot
Advances in Anticancer Protein Delivery using Micro‐/Nanoparticles
inferred← citeshttps://doi.org/10.1002/pro6.1105openalex-snapshot
Safety and efficacy of programmed cell death‐1 antibody SHR‐1210 combined with concurrent chemoradiotherapy to treat locally advanced esophageal squamous cell carcinoma: a study protocol for an exploratory single‐arm phase Ib trial
inferred← citeshttps://doi.org/10.1002/smll.201400775openalex-snapshot
Epirubicin-Loaded Superparamagnetic Iron-Oxide Nanoparticles for Transdermal Delivery: Cancer Therapy by Circumventing the Skin Barrier
inferred← citeshttps://doi.org/10.1002/smll.201600624openalex-snapshot
Stem Cell Membrane‐Coated Nanogels for Highly Efficient In Vivo Tumor Targeted Drug Delivery
inferred← citeshttps://doi.org/10.1002/smll.201801147openalex-snapshot
Peptide Nanophotonics: From Optical Waveguiding to Precise Medicine and Multifunctional Biochips
inferred← citeshttps://doi.org/10.1002/smll.202006650openalex-snapshot
Immune Stimulating Antibody‐Photosensitizer Conjugates via Fc‐Mediated Dendritic Cell Phagocytosis and Phototriggered Immunogenic Cell Death for KRAS‐Mutated Pancreatic Cancer Treatment
inferred← citeshttps://doi.org/10.1002/smtd.201700347openalex-snapshot
Immunostimulation and Immunosuppression: Nanotechnology on the Brink
inferred← citeshttps://doi.org/10.1002/sstr.202000026openalex-snapshot
Recent Progress on Activatable Nanomedicines for Immunometabolic Combinational Cancer Therapy
inferred← citeshttps://doi.org/10.1002/wnan.1421openalex-snapshot
Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?
inferred← citeshttps://doi.org/10.1002/wnan.70042openalex-snapshot
Emerging Advances in Nanomedicine for Targeted Cancer Photoimmunotherapy and Photo‐Immunometabolic Therapy
inferred← citeshttps://doi.org/10.1002/wsbm.1633openalex-snapshot
Rationalizing a prospective coupling effect of cannabinoids with the current pharmacotherapy for melanoma treatment
inferred← citeshttps://doi.org/10.1007/978-1-0716-3690-9_4openalex-snapshot
The Applications of ELISpot in the Identification and Treatment of Various Forms of Tuberculosis and in the Cancer Immunotherapies
inferred← citeshttps://doi.org/10.1007/978-1-0716-4402-7_6openalex-snapshot
Immune Cell Homing Hydrogels for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-1-4614-7876-8_18openalex-snapshot
Cancer-Specific Ligand–Receptor Interactions
inferred← citeshttps://doi.org/10.1007/978-1-4899-8056-4_14openalex-snapshot
The Hypoxia-adenosinergic Immunosuppression and Redirection of Immune Response in Tumor Microenvironment
inferred← citeshttps://doi.org/10.1007/978-1-4939-1417-3_13openalex-snapshot
Dendritic Cell-Based Vaccines
inferred← citeshttps://doi.org/10.1007/978-1-4939-1510-1_2openalex-snapshot
Immune Surveillance and Cancer Pathogenesis
inferred← citeshttps://doi.org/10.1007/978-1-4939-3634-2_10openalex-snapshot
Polymer-Based DNA Delivery Systems for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-1-4939-6631-8_69-1openalex-snapshot
Epigenetic Pharmacology
inferred← citeshttps://doi.org/10.1007/978-1-4939-7193-0_69openalex-snapshot
Epigenetic Pharmacology
inferred← citeshttps://doi.org/10.1007/978-1-907673-94-8_1openalex-snapshot
Introduction and Background Biology
inferred← citeshttps://doi.org/10.1007/978-3-030-04861-7_12openalex-snapshot
Immunomodulation and Immunotherapy for Gastric Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-28333-9_2openalex-snapshot
Renal Cell Carcinoma: Oncologist Point of View
inferred← citeshttps://doi.org/10.1007/978-3-030-30845-2_27openalex-snapshot
Envisioning the Application of Systems Biology in Cancer Immunology
inferred← citeshttps://doi.org/10.1007/978-3-030-38862-1_9openalex-snapshot
Translational Biomarkers and Rationale Strategies to Overcome Resistance to Immune Checkpoint Inhibitors in Solid Tumors
inferred← citeshttps://doi.org/10.1007/978-3-030-43032-0_10openalex-snapshot
Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020s
inferred← citeshttps://doi.org/10.1007/978-3-030-58080-3_94-1openalex-snapshot
AIM in Oncology
inferred← citeshttps://doi.org/10.1007/978-3-030-63389-9_10openalex-snapshot
Nanocarriers for the Diagnosis and Treatment of Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-64573-1_94openalex-snapshot
AIM in Oncology
inferred← citeshttps://doi.org/10.1007/978-3-030-73909-6_52openalex-snapshot
Current Trends in Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_220-1openalex-snapshot
Immunotherapy for Colorectal Cancer
inferred← citeshttps://doi.org/10.1007/978-3-031-14848-4_6openalex-snapshot
Polymeric Nanoparticles to Entrap Natural Drugs for Cancer Therapy
inferred← citeshttps://doi.org/10.1007/978-3-031-23621-1_7openalex-snapshot
A Comprehensive Review of the Impact of the Renin Angiotensin System in the Liver, Lung, Infectious Diseases and Cancers
inferred← citeshttps://doi.org/10.1007/978-3-031-27156-4_2openalex-snapshot
Transforming Diagnosis and Therapeutics Using Cancer Genomics
inferred← citeshttps://doi.org/10.1007/978-3-031-33533-4_12openalex-snapshot
Cardiotoxicity of Targeted Therapies: Imaging of Heart Does Matter
inferred← citeshttps://doi.org/10.1007/978-3-031-59478-6_16openalex-snapshot
Nanoparticles and Cancer Chemotherapy
inferred← citeshttps://doi.org/10.1007/978-3-031-71180-0_23openalex-snapshot
New Agents
inferred← citeshttps://doi.org/10.1007/978-3-032-00769-8_220openalex-snapshot
Immunotherapy for Colorectal Cancer
inferred← citeshttps://doi.org/10.1007/978-3-032-01356-9_12openalex-snapshot
Medicinal Plants in Combination Therapies for Cancer
inferred← citeshttps://doi.org/10.1007/978-3-032-11531-7_9openalex-snapshot
AI in Head and Neck Cancer Screening
inferred← citeshttps://doi.org/10.1007/978-3-032-24071-2_8openalex-snapshot
Targeted Therapies and Molecular Profiling in Cervical Cancer: A Precision Medicine Perspective
inferred← citeshttps://doi.org/10.1007/978-3-319-04843-7_18openalex-snapshot
Genetically Modified T-Cell Therapy for Osteosarcoma
inferred← citeshttps://doi.org/10.1007/978-3-319-08084-0_8openalex-snapshot
Nanotechnology Approaches for Cancer Immunotherapy and Immunomodulation
inferred← citeshttps://doi.org/10.1007/978-3-319-16555-4_13openalex-snapshot
Cancer Nanotherapeutics in Clinical Trials
inferred← citeshttps://doi.org/10.1007/978-3-319-21167-1_3openalex-snapshot
T Cell Fate in the Tumor Microenvironment
inferred← citeshttps://doi.org/10.1007/978-3-319-28140-7_58openalex-snapshot
Vascular Endothelial Growth Factor (VEGF)
inferred← citeshttps://doi.org/10.1007/978-3-319-28216-9_1openalex-snapshot
Introduction and background biology
inferred← citeshttps://doi.org/10.1007/978-3-319-28386-9_1openalex-snapshot
Blood
inferred← citeshttps://doi.org/10.1007/978-3-319-29827-6_1openalex-snapshot
Enhancing the Efficacy of Checkpoint Blockade Through Combination Therapies
inferred← citeshttps://doi.org/10.1007/978-3-319-32110-3_11openalex-snapshot
The Future in Ovarian Cancer: Advances in Immunotherapies
inferred← citeshttps://doi.org/10.1007/978-3-319-39406-0_8openalex-snapshot
Novel Approaches to Apoptosis-Inducing Therapies
inferred← citeshttps://doi.org/10.1007/978-3-319-41319-8_7openalex-snapshot
Altered Signal Transduction Pathways in Melanoma
inferred← citeshttps://doi.org/10.1007/978-3-319-45433-7_12openalex-snapshot
T-Cell Mediated Immunomodulation and Transplant Optimization
inferred← citeshttps://doi.org/10.1007/978-3-319-62431-0_21openalex-snapshot
PD-1 Blockade in Renal Cell Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-319-63757-0_9openalex-snapshot
Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials
inferred← citeshttps://doi.org/10.1007/978-3-319-64550-6_16openalex-snapshot
Cancer Immunotherapy: Friend or Foe of Mental Health?
inferred← citeshttps://doi.org/10.1007/978-3-319-64958-0_1openalex-snapshot
Vaccine Approaches in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-662-44006-3_23openalex-snapshot
Envisioning the Application of Systems Biology in Cancer Immunology
inferred← citeshttps://doi.org/10.1007/978-3-662-46410-6_2openalex-snapshot
Vaccination in Human Solid Tumors: Recent Progress in the Clinical Arena
inferred← citeshttps://doi.org/10.1007/978-3-662-46410-6_9openalex-snapshot
Tumor Immunotherapy of Esophageal and Gastric Cancers
inferred← citeshttps://doi.org/10.1007/978-3-662-70915-3_20openalex-snapshot
Besonderheiten des hämatoonkologischen Arzneimittelmarkts
inferred← citeshttps://doi.org/10.1007/978-3-7091-0371-5_7openalex-snapshot
Altered Signal Transduction Pathways in Melanoma
inferred← citeshttps://doi.org/10.1007/978-3-7091-1300-4_1openalex-snapshot
Immune Cells Within the Tumor Microenvironment
inferred← citeshttps://doi.org/10.1007/978-4-431-55327-4_3openalex-snapshot
The Role of Innate Immune Signaling in Regulation of Tumor-Associated Myeloid Cells
inferred← citeshttps://doi.org/10.1007/978-4-431-55666-4_5openalex-snapshot
Cell-Based Immunotherapy for HCC: Our Experiences and Future Directions
inferred← citeshttps://doi.org/10.1007/978-94-007-6217-6_1openalex-snapshot
Role of the Immunological Environment in Cancer Initiation, Development and Progression
inferred← citeshttps://doi.org/10.1007/978-94-007-6262-6_10openalex-snapshot
Generation of Antigen-Specific T Lymphocytes from Induced Pluripotent Stem Cells for Adoptive Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-94-017-7555-7_4openalex-snapshot
Adoptive Cellular Therapy (ACT) for Cancer Treatment
inferred← citeshttps://doi.org/10.1007/978-981-10-6469-2_7openalex-snapshot
Molecular Diagnosis and Targeting of Biliary Tract Cancer
inferred← citeshttps://doi.org/10.1007/978-981-10-7013-6_40openalex-snapshot
Gene Therapy for Prostate Cancer: Current Status and Future Prospects
inferred← citeshttps://doi.org/10.1007/978-981-16-1247-3_105-1openalex-snapshot
Delineating the Role of PI3K Signaling Pathway in the Stem Cell Therapeutics of ROS-Induced Carcinomas
inferred← citeshttps://doi.org/10.1007/978-981-16-1247-3_97-1openalex-snapshot
Regenerative Medicines for ROS-Induced Cancers Treatment
inferred← citeshttps://doi.org/10.1007/978-981-16-1313-5_100-1openalex-snapshot
Nanomaterials for Therapeutic Nucleic Acid Delivery
inferred← citeshttps://doi.org/10.1007/978-981-16-5422-0_105openalex-snapshot
Delineating the Role of PI3K Signaling Pathway in the Stem Cell Therapeutics of ROS-Induced Carcinomas
inferred← citeshttps://doi.org/10.1007/978-981-16-5422-0_97openalex-snapshot
Regenerative Medicines for ROS-Induced Cancers Treatment
inferred← citeshttps://doi.org/10.1007/978-981-16-7606-2_16openalex-snapshot
Role of Immunotherapy in Ameliorating Proteopathic Dementia
inferred← citeshttps://doi.org/10.1007/978-981-19-9776-1_100openalex-snapshot
Nanomaterials for Therapeutic Nucleic Acid Delivery
inferred← citeshttps://doi.org/10.1007/978-981-95-7358-5_4openalex-snapshot
Types of Photocarcinoma
inferred← citeshttps://doi.org/10.1007/978-981-96-2171-2_4openalex-snapshot
Carbohydrate Polymer Nanocomposites Used in Cancer Imaging and Therapy
inferred← citeshttps://doi.org/10.1007/978-981-96-3041-7_23openalex-snapshot
RNA Nanotechnology: The Fundamentals
inferred← citeshttps://doi.org/10.1007/978-981-96-3659-4_7openalex-snapshot
The Combination of Immunotherapy and Radiotherapy in Pancreatic Ductal Adenocarcinoma
inferred← citeshttps://doi.org/10.1007/978-981-96-8176-1_16openalex-snapshot
Artificial Intelligence and Cancer Immunotherapy
inferred← citeshttps://doi.org/10.1007/978-981-97-1666-1_7openalex-snapshot
Epigenetic Alterations as an Adaptive Response to Chemotherapy
inferred← citeshttps://doi.org/10.1007/978-981-97-4970-6_14openalex-snapshot
Targeted Tumor Delivery
inferred← citeshttps://doi.org/10.1007/978-981-99-0313-9_14openalex-snapshot
Tumor-on-a-Chip: Microfluidic Models of Hypoxic Tumor Microenvironment
inferred← citeshttps://doi.org/10.1007/978-981-99-1421-0_1openalex-snapshot
General Introduction
inferred← citeshttps://doi.org/10.1007/s00108-015-3744-6openalex-snapshot
Immunologische Tumortherapie
inferred← citeshttps://doi.org/10.1007/s00109-013-1001-9openalex-snapshot
Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer
inferred← citeshttps://doi.org/10.1007/s00109-015-1376-xopenalex-snapshot
Immunosuppressive cells in tumor immune escape and metastasis
inferred← citeshttps://doi.org/10.1007/s00134-013-3148-9openalex-snapshot
De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study
inferred← citeshttps://doi.org/10.1007/s00134-014-3615-yopenalex-snapshot
Prognosis of neutropenic patients admitted to the intensive care unit
inferred← citeshttps://doi.org/10.1007/s00204-022-03423-xopenalex-snapshot
Mycotoxins and cellular senescence: the impact of oxidative stress, hypoxia, and immunosuppression
inferred← citeshttps://doi.org/10.1007/s00253-015-6384-9openalex-snapshot
Current understanding of synergistic interplay of chitosan nanoparticles and anticancer drugs: merits and challenges
inferred← citeshttps://doi.org/10.1007/s00261-024-04499-yopenalex-snapshot
From guidelines to radiology practice: navigating the 2023 ASCO guidelines for advanced gastroesophageal cancer and beyond
inferred← citeshttps://doi.org/10.1007/s00262-013-1474-yopenalex-snapshot
Antitumor immune responses induced by ionizing irradiation and further immune stimulation
inferred← citeshttps://doi.org/10.1007/s00262-015-1702-8openalex-snapshot
6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice
inferred← citeshttps://doi.org/10.1007/s00262-015-1752-yopenalex-snapshot
Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression
inferred← citeshttps://doi.org/10.1007/s00262-016-1830-9openalex-snapshot
2′–5′ Oligoadenylate synthetase-like 1 (OASL1) deficiency in mice promotes an effective anti-tumor immune response by enhancing the production of type I interferons
inferred← citeshttps://doi.org/10.1007/s00262-016-1932-4openalex-snapshot
Oncolysate-loaded Escherichia coli bacterial ghosts enhance the stimulatory capacity of human dendritic cells
inferred← citeshttps://doi.org/10.1007/s00262-017-2026-7openalex-snapshot
Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy
inferred← citeshttps://doi.org/10.1007/s00262-017-2089-5openalex-snapshot
Targeting and suppression of HER3-positive breast cancer by T lymphocytes expressing a heregulin chimeric antigen receptor
inferred← citeshttps://doi.org/10.1007/s00262-017-2091-yopenalex-snapshot
The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy
inferred← citeshttps://doi.org/10.1007/s00262-019-02370-4openalex-snapshot
Immunity to X-linked inhibitor of apoptosis protein (XIAP) in malignant melanoma and check-point blockade
inferred← citeshttps://doi.org/10.1007/s00262-022-03220-6openalex-snapshot
Improvement of STING-mediated cancer immunotherapy using immune checkpoint inhibitors as a game-changer
inferred← citeshttps://doi.org/10.1007/s00262-022-03349-4openalex-snapshot
Complete remissions following immunotherapy or immuno-oncology combinations in cancer patients: the MOUSEION-03 meta-analysis
inferred← citeshttps://doi.org/10.1007/s00262-024-03858-4openalex-snapshot
Hepatitis associated with immune checkpoint inhibitors-based combinations of other therapies: A real-world pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database
inferred← citeshttps://doi.org/10.1007/s00262-025-04011-5openalex-snapshot
A new era of cancer immunotherapy: vaccines and miRNAs
inferred← citeshttps://doi.org/10.1007/s00280-015-2849-xopenalex-snapshot
Personalizing chemotherapy dosing using pharmacological methods
showing the first 200 of 1557 · page through all 1557
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.